Wednesday, June 1, 2016

BRIEF-Nektar Therapeutics and Daiichi Sankyo Europe sign European licensing agreement for onzeald experimental treatment for breast cancer and brain metastases

… to
treat patients with advanced breast cancer and brain metastases
Source text …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)